MetaCap

Beta Bionics (BBNX) vs vVARDIS (VVVV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

vVARDIS is the larger company by market cap ($770.9 million vs $726.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BBNX-18.64%VVVV-11.82%
+1%-9%-20%
Nov 13, 20261 yearNov 20, 2026
BBNX-18.64%VVVV-11.82%
+1%-9%-20%
Nov 9, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BBNX versus VVVV key metrics
MetricBBNXVVVV
Share price$13.36$14.55
Market cap$726.34M$770.91M
1-day change+0.30%-3.00%
YTD return-56.15%—
1-year return-57.48%—
EPS (TTM)$-1.83$-0.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$100.25M—
Revenue growth (YoY)+53.94%—
Net income (latest FY)$-73.20M—
Gross margin55.40%—
Operating margin-71.50%—
Net margin-73.02%—
52-week high$32.71$16.95
52-week low$8.80$14.00
Distance from 52-week high-59.16%-14.16%
Analyst consensusbuy—
Avg. price target upside+87.87%—
Average volume1.21M963.08K
Shares outstanding54.37M38.59M
Employees420153
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Beta Bionics

BBNX stock →

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.

Health Care · Medical/Dental Instruments · 420 employees

About vVARDIS

VVVV stock →

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.

Health Care · Medical/Dental Instruments · 153 employees

BBNX vs VVVV FAQ

Which is bigger, Beta Bionics or vVARDIS?

vVARDIS (VVVV) is larger, with a market capitalization of $770.91M compared with $726.34M for Beta Bionics (BBNX).

Are Beta Bionics and vVARDIS in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons